Compass Genetics Investors

Total investments

2

Average round size

4M

Portfolio companies

1

Follow on index

0.50

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyAnalyticsGeneticsPharmaceutical

Summary

The company was established in North America in United States. The main department of described VC is located in the Dover.

The standard case for the fund is to invest in rounds with 3 partakers. Despite the Compass Genetics Investors, startups are often financed by Noble Fund Managers, Auriga Partners. The meaningful sponsors for the fund in investment in the same round are Auriga Partners, Noble Fund Managers, Beringea. In the next rounds fund is usually obtained by Auriga Partners, Beringea, Syngenta Ventures.

We can highlight the next thriving fund investment areas, such as Pharmaceutical, Analytics. Among the various public portfolio startups of the fund, we may underline Population Genetics Technologies Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United Kingdom.

The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2009.

Show more

Investments analytics

Analytics

Total investments
2
Lead investments
0
Follow on index
0.50
Investments by industry
  • Genetics (2)
  • Pharmaceutical (2)
  • Biotechnology (2)
  • Analytics (2)
Investments by region
  • United Kingdom (2)
Peak activity year
2009

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
17
Group Appearance index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Population Genetics Technologies 01 Apr 2009 Biotechnology, Analytics, Genetics, Pharmaceutical Early Stage Venture 3M United Kingdom, England, South Cambridgeshire

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.